サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：在宅化学療法サービス市場：製品タイプ別、がんタイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1419023

在宅化学療法サービス市場：製品タイプ別、がんタイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Chemotherapy At Home Services Market, By Product Type, By Cancer Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 285 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
在宅化学療法サービス市場：製品タイプ別、がんタイプ別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年01月17日
発行: AnalystView Market Insights
ページ情報: 英文 285 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

在宅化学療法サービス市場規模は2022年に15億800万米ドルと評価され、2023年から2030年にかけてCAGR 8.5％で拡大

在宅化学療法サービス市場-市場力学

化学療法在宅サービス市場の成長は、さまざまな種類のがんの罹患率の増加と、患者が病院から在宅療養環境へ移行する傾向の高まりによって牽引されると予想されます。

多くの患者は、可能な限り快適な自宅で医療を受けたいと考えています。在宅環境でヘルスケアサービスを提供することで、患者の利便性を高め、頻繁な通院の負担を軽減することができます。がん患者数が増加し続ける中、ヘルスケア施設はそのサービスに対する圧力や需要の増加に直面する可能性があります。在宅化学療法サービスは、患者が病院以外の環境で治療を受けられるようにすることで、このような重圧を軽減するのに役立ちます。National Center for Health Statisticsによると、2023年には米国で新たに195万8310人のがん患者が発生し、60万9820人ががんに関連して死亡すると予測されています。携帯型輸液ポンプや遠隔監視装置などの医療技術の進歩は、在宅化学療法サービス市場に成長機会をもたらします。しかし、安全性への懸念に対処し、これらのサービスの限定的な適用性を考慮することが重要であり、市場の成長を妨げる可能性があります。

在宅化学療法サービス市場-セグメンテーション分析：

世界の在宅化学療法サービス市場は、製品タイプ、がんタイプ、地域によって区分されます。

市場は製品タイプによって3つに分類される：経口剤と輸液剤です。市場は主に経口剤セグメントによって占められています。経口化学療法薬は錠剤やカプセルの形で入手できるため、患者は自宅で便利に服用することができます。そのため、患者にとっては柔軟性が増し、自己投与の選択肢も増えます。通常、腫瘍医は経口化学療法を処方し、患者は薬局で便利に薬を入手することができます。一部の薬局では、経口化学療法の調剤に特化したサービスを提供しています。

市場はがんタイプによって2つのカテゴリーに分けられる：乳がん、大腸がん、直腸がん、子宮頸がん、肺がん、前立腺がん、卵巣がん、白血病です。市場を独占しているのは白血病です。市場は主に白血病セグメントによって支配されています。白血病は主に急性型と慢性型に分類され、さらに骨髄型とリンパ型に分けられます。採用される治療法は、白血病の正確なタイプやサブタイプによって異なります。化学療法は白血病、特に急性型に対する一般的な治療法です。これは、白血病細胞を死滅させたり、増殖を制御するための薬剤の使用を伴うためです。

在宅化学療法サービス市場- 地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む様々な地域に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。北米の市場は、主にがん治療のための在宅輸液サービスの需要増加に牽引され、成長を独占すると予想されます。北米でがん罹患率が上昇した場合、化学療法などのがん治療サービスの需要が急増する可能性が高いです。このような需要の増加は、在宅サービスのような、より便利で患者に優しい選択肢の必要性につながる可能性があります。毎年約170万人のアメリカ人ががんと診断されると推定されています。診断から1年以内に、進行がん患者の4分の3が入院し、6人に1人が3回以上入院しています。さらに、Frontiers of Health and Medicine誌が報告しているように、化学療法を必要とするほとんどすべての人が、医師の診察室や外来診療所で1日に数時間を費やしています。欧州は、在宅化学療法サービスに対する需要の増加により、予測期間中の市場成長において第2位の地域となっています。

在宅化学療法サービス市場- 競合情勢：

小児がん治療の主な場所は病院であることに変わりはないが、在宅環境で治療を提供する傾向が強まっています。包括的で適切なケアが家庭で提供されるようにするためには、主要な情報提供者の視点を考慮することが極めて重要です。カナダ、米国、オーストラリア、欧州などの国々では、小児に対する在宅ケアサービスや治療を拡大しており、これには静脈内化学療法、化学療法後の水分補給、低リスクの発熱性好中球減少症のモニタリング、薬物注入などが含まれます。メーカーは、在宅がんケアサービスを改善するために、小児、家族介護者、臨床医からの意見を積極的に求めています。これには、在宅でケアを受けたり提供したりすることの利点や課題を明らかにすることや、プログラムの受容性や認知された有用性を高めるために必要な修正を加えることが含まれます。ヘルスケア企業は在宅医療提供者と協力し、在宅で化学療法を受ける患者のための支援サービスやリソースを提供しています。このような連携は、患者の教育や治療計画のアドヒアランスを向上させることを目的としています。全国的なプロバイダーだけでなく、地方や地域の在宅医療機関も腫瘍医や病院と連携して在宅化学療法サービスを提供し、がん治療を患者の自宅まで広げています。

目次

第1章 在宅化学療法サービス市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 在宅化学療法サービスの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 在宅化学療法サービス業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 在宅化学療法サービス市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 在宅化学療法サービスの市場情勢

  • 在宅化学療法サービス市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 在宅化学療法サービス市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 経口
    • 点滴

第8章 在宅化学療法サービス市場- がんタイプ別

  • 概要
    • がんタイプ別のセグメントシェア分析
    • 乳がん
    • 結腸がん
    • 直腸がん
    • 子宮頸がん
    • 肺がん
    • 前立腺がん
    • 卵巣がん
    • 白血病

第9章 在宅化学療法サービス市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 在宅化学療法サービス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Sciensus Pharma Services Limited
    • Portea Medical
    • Ubiqare
    • Penn Medicine（The Trustees of the University of Pennsylvania）
    • Advocate Health Care
    • View Health Pty Ltd group（chemo@home Pty Ltd）
    • Vitalis Health and Home Care Pty Ltd
    • Medibank Private Limited
    • TCP Homecare
    • LloydsPharmacy Clinical Homecare

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Chemotherapy At Home Services Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Chemotherapy At Home Services Market, by Product Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Cancer Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Chemotherapy At Home Services Market, by Cancer Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Chemotherapy At Home Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Chemotherapy At Home Services Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Cancer Type segment market share analysis, 2022 & 2030
  • FIGURE Cancer Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Chemotherapy At Home Services Market share and leading players, 2022
  • FIGURE Europe Chemotherapy At Home Services Market share and leading players, 2022
  • FIGURE Asia Pacific Chemotherapy At Home Services Market share and leading players, 2022
  • FIGURE Latin America Chemotherapy At Home Services Market share and leading players, 2022
  • FIGURE Middle East and Africa Chemotherapy At Home Services Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Chemotherapy At Home Services Market share analysis by country, 2022
  • FIGURE Germany Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Chemotherapy At Home Services Market share analysis by country, 2022
  • FIGURE India Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Chemotherapy At Home Services Market share analysis by country, 2022
  • FIGURE Brazil Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Chemotherapy At Home Services Market share analysis by country, 2022
  • FIGURE Saudi Arabia Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Chemotherapy At Home Services Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2088

REPORT HIGHLIGHT

Chemotherapy At Home Services Market size was valued at USD 1,508 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.

Chemotherapy treatment at home offers several potential advantages. Firstly, it eliminates the need for frequent travel to hospital facilities, saving patients time and energy. Additionally, there is a reduced risk of acquiring infections that are commonly associated with hospitals. By receiving treatment in the comfort and security of their own homes, patients can experience a greater sense of ease and familiarity. This also minimizes disruptions to family life, allowing patients to maintain a sense of normalcy during their treatment. Moreover, receiving chemotherapy at home can provide patients with a heightened sense of control over their treatment and illness. To ensure accurate and up-to-date information on available services and any changes in the delivery of chemotherapy treatments, it is crucial to consult with healthcare providers or contact local healthcare authorities. While home healthcare services may be available for certain aspects of cancer care, such as home health nursing, supportive care, or palliative care, it is important to note that the administration of chemotherapy drugs may still require a controlled medical setting.

Chemotherapy At Home Services Market- Market Dynamics

The growth of the Chemotherapy At Home Services market is expected to be driven by the increasing incidence of different types of cancer and the growing trend of patients transitioning from hospital to home care settings.

Many individuals express a preference for receiving medical care in the comfort of their own homes whenever possible. By providing healthcare services in a home-based setting, it can enhance patient convenience and alleviate the burden of frequent hospital visits. As the number of cancer cases continues to rise, healthcare facilities may face increased pressure and demand for their services. Home-based chemotherapy services can help alleviate some of this pressure by allowing patients to receive treatment in a non-hospital environment. According to the National Center for Health Statistics, it is projected that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. The advancement of medical technology, such as portable infusion pumps and remote monitoring devices, presents a growth opportunity for the chemotherapy at home services market. However, it is important to address safety concerns and consider the limited applicability of these services, as they may hinder the market's growth.

Chemotherapy At Home Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global Chemotherapy At Home Services market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)
  • Based on product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Cancer Type segmentation, Leukemia was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Chemotherapy At Home Services Market- Segmentation Analysis:

The Global Chemotherapy At Home Services Market is segmented on the basis of Product Type, Cancer Type and Region.

The market is divided into three categories based on product type: Oral and Infusion. The market is primarily dominated by the oral segment. Oral chemotherapy drugs are available in the form of pills or capsules, enabling patients to conveniently take them at home. This provides them with increased flexibility and the option of self-administration. Oncologists usually prescribe oral chemotherapy, and patients can conveniently obtain their medications from pharmacies. Certain pharmacies even provide specialized services for dispensing oral chemotherapy.

The market is divided into two categories based on Cancer Type: Breast Cancer, Colon Cancer, Rectum Cancer, Cervix Uteri Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer and Leukemia. Leukemia segment dominates the market. The market is predominantly controlled by the leukemia segment. Leukemia is classified into two main forms, namely acute and chronic, and further divided into myeloid and lymphoid types. The treatment methods employed depend on the precise type and subtype of leukemia. Chemotherapy is a common treatment modality for leukemia, particularly for acute forms. It involves the use of drugs to kill or control the growth of leukemia cells.

Chemotherapy At Home Services Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market in North America is expected to dominate the growth, primarily driven by the increasing demand for home infusion services for cancer treatment. In the event of a rise in cancer incidence in North America, there would likely be a surge in the demand for cancer treatment services, such as chemotherapy. This growing demand could lead to a need for more convenient and patient-friendly options like home-based services. It is estimated that approximately 1.7 million Americans are diagnosed with cancer each year. Within a year of diagnosis, three-quarters of those with advanced cancer end up being hospitalized, with 1 in 6 individuals being hospitalized three or more times. Additionally, almost everyone requiring chemotherapy spends several hours a day in physician offices or outpatient clinics, as reported by the frontiers of health and medicine. Europe holds the second-largest region for market growth during the forecast period, owing to the increasing demand for home-based chemotherapy services.

Chemotherapy At Home Services Market- Competitive Landscape:

While hospitals continue to be the primary location for pediatric cancer care, there is a growing trend towards providing care in the home setting. To ensure that comprehensive and appropriate care is delivered to children in their homes, it is crucial to consider the perspectives of key informants. Countries such as Canada, the United States, Australia, and Europe are expanding their home care services and treatments for children, including intravenous chemotherapy, post-chemotherapy hydration, monitoring of low-risk febrile neutropenia, and medication infusions. Manufacturers are actively seeking input from children, family caregivers, and clinicians to improve home-based cancer care services. This includes identifying the benefits and challenges associated with receiving or providing care at home, as well as making necessary modifications to enhance program acceptability and perceived usefulness. Pharmaceutical companies are collaborating with home healthcare providers to offer support services and resources for patients undergoing chemotherapy at home. These collaborations aim to improve patient education and adherence to treatment plans. In addition to national providers, local and regional home healthcare agencies may also offer at-home chemotherapy services in partnership with oncologists and hospitals, thereby extending cancer care to patients' homes.

Recent Developments:

In July 2023, a strategic alliance was formed between DispatchHealth and Reimagine Care to facilitate at-home cancer treatment. The collaboration lowers emergency room visits and unanticipated hospital stays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET KEY PLAYERS

  • Portea Medical
  • Ubiqare
  • Penn Medicine (The Trustees of the University of Pennsylvania)
  • Advocate Health Care
  • View Health Pty Ltd group (chemo@home Pty Ltd)
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited
  • TCP Homecare
  • LloydsPharmacy Clinical Homecare

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY PRODUCT TYPE

  • Oral
  • Infusion

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY CANCER TYPE

  • Breast Cancer
  • Colon Cancer
  • Rectum Cancer
  • Cervix Uteri Cancer
  • Lung Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Leukemia

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chemotherapy At Home Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chemotherapy At Home Services Market Snippet by Product Type
    • 2.1.2. Chemotherapy At Home Services Market Snippet by Cancer Type
    • 2.1.3. Chemotherapy At Home Services Market Snippet by Country
    • 2.1.4. Chemotherapy At Home Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Chemotherapy At Home Services Key Market Trends

  • 3.1. Chemotherapy At Home Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chemotherapy At Home Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chemotherapy At Home Services Market Opportunities
  • 3.4. Chemotherapy At Home Services Market Future Trends

4. Chemotherapy At Home Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chemotherapy At Home Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chemotherapy At Home Services Market Landscape

  • 6.1. Chemotherapy At Home Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chemotherapy At Home Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
    • 7.1.3. Infusion

8. Chemotherapy At Home Services Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2022 & 2030 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Colon Cancer
    • 8.1.4. Rectum Cancer
    • 8.1.5. Cervix Uteri Cancer
    • 8.1.6. Lung Cancer
    • 8.1.7. Prostate Cancer
    • 8.1.8. Ovarian Cancer
    • 8.1.9. Leukemia

9. Chemotherapy At Home Services Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Chemotherapy At Home Services Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Chemotherapy At Home Services Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Chemotherapy At Home Services Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Chemotherapy At Home Services Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Chemotherapy At Home Services Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Chemotherapy At Home Services Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Sciensus Pharma Services Limited
    • 10.2.2. Portea Medical
    • 10.2.3. Ubiqare
    • 10.2.4. Penn Medicine (The Trustees of the University of Pennsylvania)
    • 10.2.5. Advocate Health Care
    • 10.2.6. View Health Pty Ltd group (chemo@home Pty Ltd)
    • 10.2.7. Vitalis Health and Home Care Pty Ltd
    • 10.2.8. Medibank Private Limited
    • 10.2.9. TCP Homecare
    • 10.2.10. LloydsPharmacy Clinical Homecare

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us